BIOCOMMUNIQUE

BIOCOM Newsletter

BIOCOM Event Spotlight

August Medical Device

BIOCOM August Medical Device Event The Life of a Product Liability Claim...Who is the Real Victim?

More Information

Investor Conference

The third annual BIOCOM Investor Conference is a unique opportunity to gain access to leading technology from Southern California, one of the industry’s largest life science communities, with over 800 companies producing life saving technologies and products to improve quality of life for patients.

More Information

BIOCOM Supplier Showcase

Join BIOCOM Purchasing Group for a fun filled afternoon of networking, drinks, delicious appetizers and fabulous giveaways in the relaxing environment of our courtyard.

More Information

PR Newswire Life Science Press Releases

Welcome to BIOCOM

BIOCOM is the largest regional life science association in the world, representing more than 575 member companies in Southern California. The association focuses on initiatives that positively influence the region’s life science community in the development and delivery of innovative products that improve health and quality of life. This includes initiatives in public policy, capital formation, workforce development, group purchasing and member services such as networking events.

BIOCOM provides for favorable government policies on the local, state and federal levels, attracts investment dollars to the region, saves your company money when buying commodity products, develops the workforce for the biotech and medical device community, and helps build your professional network through meetings and events. Join BIOCOM today.

Premium Member Spotlight

Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati has developed a broad expertise in the field of life sciences. The firm's Life Sciences practice includes representation of more than 300 companies in biotechnology, biopharmaceuticals, drug discovery technology, genomics, medical devices, diagnostics, and healthcare services. We regularly advise life sciences companies on both public and private equity and debt financings, mergers and acquisitions, research and development financings, technology licensing and contracts, as well as day-to-day securities and corporate governance matters. Since 1998, Wilson Sonsini Goodrich & Rosati has served as counsel to companies and investment banks in more than 170 public offerings involving life sciences companies, raising more than $12.4 billion. The life sciences attorneys maintain close ties with venture capital funds most active in the space, and have represented more life sciences companies in the process of securing venture capital financing than any other law firm. Over the last five years, we have assisted our life sciences clients in raising more than $1.5 billion in venture capital financing. We also are a leader in structuring and negotiating corporate alliances for a full range of business objectives. The firm has counseled more than 100 life sciences companies regarding the structure of major corporate collaborations. To assist life sciences companies with the protection and exploitation of their intellectual property, the firm maintains a dedicated team of intellectual property attorneys led by industry veterans with significant experience securing and defending patent positions. The firm runs a dedicated healthcare regulatory law practice to help life sciences clients successfully navigate complex regulatory mazes, secure timely approvals, and comply with strictly enforced regulatory laws in the U.S. and international markets. The firm adapts its services to account for the different conditions in the life sciences industry, such as longer product development timetables, regulatory and reimbursement issues, and unique relationships with the scientific and medical communities. Our team includes attorneys and patent agents with advanced, technical, or scientific degrees and industry experience to better serve the needs of our clients.